HomeREGULATORY
REGULATORY

Pfizer’s Breast Cancer Med Palbociclib Up for MHLW Panel Review on July 27
(Jul.14.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will review on July 27 whether to recommend approval for a batch of drugs including Pfizer’s breast cancer drug palbociclib, known as Ibrance overseas ...
(LOG IN FOR FULL STORY)

News Calendar